These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8098506)

  • 1. [Successful prevention of rhinovirus infections with chimeric ICAM-1 immunoglobulin in vitro].
    Martin S; Casanovas JM; Staunton DE; Springer TA
    Med Klin (Munich); 1993 Apr; 88(4):193-7. PubMed ID: 8098506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection.
    Marlin SD; Staunton DE; Springer TA; Stratowa C; Sommergruber W; Merluzzi VJ
    Nature; 1990 Mar; 344(6261):70-2. PubMed ID: 1968231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules.
    Martin S; Casasnovas JM; Staunton DE; Springer TA
    J Virol; 1993 Jun; 67(6):3561-8. PubMed ID: 8098781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196.
    Fang F; Yu M
    J Antimicrob Chemother; 2004 Jan; 53(1):23-5. PubMed ID: 14657090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A molecule.
    Crump CE; Arruda E; Hayden FG
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1425-7. PubMed ID: 7916558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple model to predict the effectiveness of molecules that block attachment of human rhinoviruses and other viruses.
    Wickham TJ; Shuler ML; Hammer DA
    Biotechnol Prog; 1995; 11(2):164-70. PubMed ID: 7766100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1.
    Staunton DE; Gaur A; Chan PY; Springer TA
    J Immunol; 1992 May; 148(10):3271-4. PubMed ID: 1349619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levocetirizine inhibits rhinovirus-induced ICAM-1 and cytokine expression and viral replication in airway epithelial cells.
    Jang YJ; Wang JH; Kim JS; Kwon HJ; Yeo NK; Lee BJ
    Antiviral Res; 2009 Mar; 81(3):226-33. PubMed ID: 19110001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells.
    Sasaki T; Yamaya M; Yasuda H; Inoue D; Yamada M; Kubo H; Nishimura H; Sasaki H
    Eur J Pharmacol; 2005 Feb; 509(2-3):201-10. PubMed ID: 15733557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant CD36 inhibits oxLDL-induced ICAM-1-dependent monocyte adhesion.
    Stewart BW; Nagarajan S
    Mol Immunol; 2006 Feb; 43(3):255-67. PubMed ID: 16199262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion.
    Hoover-Litty H; Greve JM
    J Virol; 1993 Jan; 67(1):390-7. PubMed ID: 8093221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: rhinoviruses and their ICAM receptors.
    Bella J; Rossmann MG
    J Struct Biol; 1999 Dec; 128(1):69-74. PubMed ID: 10600561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of chimeric nectin-1(HveC)-related receptors to demonstrate that ability to bind alphaherpesvirus gD is not necessarily sufficient for viral entry.
    Geraghty RJ; Fridberg A; Krummenacher C; Cohen GH; Eisenberg RJ; Spear PG
    Virology; 2001 Jul; 285(2):366-75. PubMed ID: 11437670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements for mucosal vascular addressin binding to its lymphocyte receptor alpha 4 beta 7. Common themes among integrin-Ig family interactions.
    Briskin MJ; Rott L; Butcher EC
    J Immunol; 1996 Jan; 156(2):719-26. PubMed ID: 8543825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-rhinovirus-specific activity of the alpha-sympathomimetic oxymetazoline.
    Koelsch S; Tschaikin M; Sacher F
    Arzneimittelforschung; 2007; 57(7):475-82. PubMed ID: 17803062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of the human intercellular adhesion molecule-1, the human rhinovirus major group receptor.
    Giranda VL; Chapman MS; Rossmann MG
    Proteins; 1990; 7(3):227-33. PubMed ID: 1972986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of monoclonal antibody epitopes and critical residues for rhinovirus binding in domain 1 of intercellular adhesion molecule 1.
    McClelland A; deBear J; Yost SC; Meyer AM; Marlor CW; Greve JM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7993-7. PubMed ID: 1716769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies of the antirhinovirus activity of soluble intercellular adhesion molecule-1.
    Arruda E; Crump CE; Marlin SD; Merluzzi VJ; Hayden FG
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1186-91. PubMed ID: 1358025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of molecular interactions between intercellular adhesion molecule-1 and leukocyte function- associated antigen-1.
    Woska JR; Morelock MM; Jeanfavre DD; Bormann BJ
    J Immunol; 1996 Jun; 156(12):4680-5. PubMed ID: 8648112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral evolution toward change in receptor usage: adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells.
    Reischl A; Reithmayer M; Winsauer G; Moser R; Gösler I; Blaas D
    J Virol; 2001 Oct; 75(19):9312-9. PubMed ID: 11533194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.